M
Mitra K. Nadim
Researcher at University of Southern California
Publications - 79
Citations - 5849
Mitra K. Nadim is an academic researcher from University of Southern California. The author has contributed to research in topics: Acute kidney injury & Liver transplantation. The author has an hindex of 27, co-authored 72 publications receiving 4052 citations. Previous affiliations of Mitra K. Nadim include Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
Lakhmir S. Chawla,Rinaldo Bellomo,Azra Bihorac,Stuart L. Goldstein,Edward D. Siew,Sean M. Bagshaw,D B Bittleman,Dinna N. Cruz,Zoltan H. Endre,Robert L. Fitzgerald,Lui G. Forni,Sandra L. Kane-Gill,Eric Hoste,Jay L. Koyner,Kathleen D. Liu,Etienne Macedo,Ravindra L. Mehta,Patrick T. Murray,Mitra K. Nadim,Marlies Ostermann,Paul M. Palevsky,Neesh Pannu,Mitchell H. Rosner,Ron Wald,Alexander Zarbock,Claudio Ronco,John A. Kellum +26 more
TL;DR: The Acute Disease Quality Initiative (ADQI) proposes definitions, staging criteria for AKD, and strategies for the management of affected patients, and makes recommendations for areas of future research, which aim to improve understanding of the underlying processes and improve outcomes for patients with AKD.
Journal ArticleDOI
Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension Results From the Double-Blind, Randomized, Placebo-Controlled Rheos Pivotal Trial
John D. Bisognano,George L. Bakris,Mitra K. Nadim,Luis A. Sanchez,Abraham A. Kroon,Jill E. Schafer,Peter W. de Leeuw,Domenic A. Sica +7 more
TL;DR: The weight of the overall evidence suggests that over the long-term, BAT can safely reduce SBP in patients with resistant hypertension.
Journal ArticleDOI
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.
Mitra K. Nadim,Lui G. Forni,Lui G. Forni,Ravindra L. Mehta,Michael J. Connor,Kathleen D. Liu,Marlies Ostermann,Thomas Rimmelé,Alexander Zarbock,Samira Bell,Azra Bihorac,Vincenzo Cantaluppi,Eric Hoste,Faeq Husain-Syed,Michael J. Germain,Stuart L. Goldstein,Shruti Gupta,Michael Joannidis,Kianoush Kashani,Jay L. Koyner,Matthieu Legrand,Nuttha Lumlertgul,Sumit Mohan,Neesh Pannu,Zhiyong Peng,Xose L. Perez-Fernandez,Peter Pickkers,John R. Prowle,Thiago Reis,Nattachai Srisawat,Nattachai Srisawat,Ashita Tolwani,Anitha Vijayan,Gianluca Villa,Li Yang,Claudio Ronco,John A. Kellum +36 more
TL;DR: This Consensus Statement from the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI and for areas of future research, with the aim of improving understanding of the underlying processes and outcomes for patients with CO VID- 19 AKI.
Journal ArticleDOI
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis
Florence Wong,Mitra K. Nadim,John A. Kellum,Francesco Salerno,Rinaldo Bellomo,Alexander L. Gerbes,Paolo Angeli,Richard Moreau,Andrew Davenport,Rajiv Jalan,Claudio Ronco,Yuri Genyk,Vicente Arroyo +12 more
TL;DR: Accepting this new classification will allow studies into the epidemiology, incidence, prevalence, natural history and the development of new treatments for these subtypes of renal dysfunction in cirrhosis.
Journal ArticleDOI
An overview of drug-induced acute kidney injury.
Neesh Pannu,Mitra K. Nadim +1 more
TL;DR: A comprehensive strategy should be used to avoid nephrotoxicity in critically ill patients including: accurate estimation of pre-existing renal function using serum creatinine–based glomerular filtration rates, avoidance of neph Rotoxins if possible, ongoing monitoring of renal function, and immediate discontinuation of suspected neph rotoxins in the event of renal dysfunction.